Morningside

0 followers

About Morningside

The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.

Recent News

CellCentric Initiates DOMMINO-1, a Pivotal Phase 2 Clinical Trial of Inobrodib in Combination with Pomalidomide and Dexamethasone (InoPd) in Relapsed or Refractory Multiple Myeloma

Recent Deals

Brook.ai Raises $28M Series B to Expand AI-Powered Remote Care

October 16, 2025

SimpliFed Raises $10.8M Series A Led by Morningside and Hesperia Capital

April 7, 2026

Brook.ai Raises $28M Series B to Scale AI-Driven Remote Patient Care

October 16, 2025

Morningside

About Morningside

Recent News

Recent Deals

Ask Pulse AI:

Technology Pulse